Neuroscience, Neuromodulation, Neural Implants.
Depending how you count, at a market cap of $6 billion, Nevro Corporation might be considered one of the “big four.” Nevro is primarily focused on an SCS pain relief. Interesting note is that Nevro characterizes it’s Senza® SCS system as “an evidence-based neuromodulation platform.” Avanos Medical